Truist Securities Reiterates Hold on Zimmer Biomet Holdings, Lowers Price Target to $112
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Hold rating on Zimmer Biomet Holdings and lowered the price target from $117 to $112.
September 13, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Truist Securities has maintained its Hold rating on Zimmer Biomet Holdings but has reduced the price target from $117 to $112, indicating a cautious outlook.
The lowering of the price target by Truist Securities suggests a less optimistic view on Zimmer Biomet's short-term performance, which could lead to a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100